Table 1.
Baseline Patient Participant Characteristics by Study Arm (N=524)
| Usual Care (N=188 patients, 27 PCPs) N (%) |
CDSS (N=165 patients, 25 PCPs) N (%) |
CDSS Plus (N=171 patients, 28 PCPs) N (%) |
Total (N=524 patients, 80 PCPs) N (%) |
p-value* | |
|---|---|---|---|---|---|
| Age (years): mean ± SD | 71.1 ± 8.4 | 70.2 ± 8.6 | 69.4 ± 9.6 | 70.3 ± 8.9 | 0.4 |
| Gender | |||||
| Female | 75 (39.9) | 75 (45.5) | 86 (50.3) | 236 (45.0) | 0.4 |
| Male | 113 (60.1) | 90 (54.5) | 85 (49.7) | 288 (55.0) | |
| Race/ethnicity | |||||
| White | 99 (52.7) | 98 (59.8) | 80 (46.8) | 277 (53.0) | 0.2 |
| Black/African American | 17 (9.0) | 21 (12.8) | 31 (18.1) | 69 (13.2) | |
| Asian | 53 (28.2) | 29 (17.7) | 35 (20.5) | 117 (22.4) | |
| Hispanic | 15 (8.0) | 9 (5.5) | 14 (8.2) | 38 (7.3) | |
| Other | 4 (2.1) | 7 (4.3) | 11 (6.4) | 22 (4.2) | |
| Preferred language | |||||
| English | 159 (84.6) | 153 (92.7) | 157 (91.8) | 469 (89.5) | 0.4 |
| Chinese | 22 (11.7) | 9 (5.5) | 8 (4.7) | 39 (7.4) | |
| Spanish | 7 (3.7) | 3 (1.8) | 6 (3.5) | 16 (3.1) | |
| Co-morbidities | |||||
| Cerebrovascular disease | 17 (9.0) | 9 (5.5) | 10 (5.8) | 36 (6.9) | 0.3 |
| Congestive heart failure | 17 (9.0) | 14 (8.5) | 9 (5.3) | 40 (7.6) | 0.4 |
| Coronary artery disease | 39 (20.7) | 29 (17.6) | 27 (15.8) | 95 (18.1) | 0.5 |
| Diabetes mellitus | 75 (39.9) | 55 (33.3) | 69 (40.4) | 199 (38.0) | 0.3 |
| Hyperlipidemia | 115 (61.2) | 97 (58.8) | 90 (52.6) | 302 (57.6) | 0.4 |
| Hypertension | 137 (72.9) | 122 (73.9) | 118 (69.0) | 377 (72.0) | 0.6 |
| Medication use | |||||
| ACEi/ARB | 115 (61.2) | 102 (61.8) | 102 (59.7) | 319 (60.9) | 0.9 |
| Diuretic | 73 (38.8) | 66 (40.0) | 60 (35.1) | 199 (38.0) | 0.5 |
| Statin | 136 (72.3) | 107 (64.9) | 110 (64.3) | 353 (67.4) | 0.3 |
| CKD related variables | |||||
| Had albuminuria test | 90 (47.9) | 59 (35.8) | 71 (41.5) | 220 (42.0) | 0.3 |
| CKD diagnosis | 98 (52.1) | 78 (47.3) | 71 (41.5) | 247 (47.1) | 0.3 |
| Systolic BP (mm Hg) [median, IQR] | 130 [118–142] | 126 [116–137] | 131 [118–143] | 128 [117–140] | 0.2 |
| Diastolic BP (mm Hg) [median, IQR] | 68 [63–75] | 68 [62–76] | 68 [63–73] | 68 [63–75] | 0.8 |
| BP controlled (<140/90) | 130 (69.2) | 128 (77.6) | 115 (67.3) | 373 (71.2) | 0.09 |
| eGFRcr (mL/min) mean ± SD | 56 ± 12.2 | 55 ± 11.5 | 58 ± 11.4 | 56 ± 11.8 | 0.1 |
*
p-values account for clustering of patients within physicians.